MedPath

To assess the effect of transversus abdominis plane (TAP) block to control pain after removal of uterus.

Not Applicable
Conditions
Health Condition 1: N719- Inflammatory disease of uterus, unspecified
Registration Number
CTRI/2020/05/025379
Lead Sponsor
Tata Motors Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. ASA grade I-III

2. Total abdominal hysterectomy done via lower abdominal transverse (Pfannenstiel) incision.

Exclusion Criteria

1. Patient refusal.

2. A history of drug allergy or local anaesthetic toxicity.

3. BMI >35kg/m2 (to limit maximum Ropivacaine dose to 3mg/kg)

4. Contraindications to regional anaesthesia (bleeding diathesis, infection at the site of block and peripheral neuropathy)

5. Change of anaesthetic technique to general anaesthesia.

6. Failure or complication in epidural catheter insertion.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath